FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Enalaprilat Injection, USP
Status: Currently in Shortage
»Date first posted: 03/29/2019
»Therapeutic Categories: Cardiovascular

Expand all

Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Revised 12/13/2019)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
2.5mg/2mL, vial (NDC 0143-9786-10) This presentation is temporarily on backorder. Additional lots will be scheduled for manufacturing Product will be made available as it is released. Demand increase for the drug
1.25mg/mL, vial (NDC 0143-9787-10) This presentation is temporarily on backorder. Additional lots will be scheduled for manufacturing Product will be made available as it is released. Demand increase for the drug

Hospira, Inc. (Reverified 12/06/2019)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1.25 mg/mL; Single Dose Glass Fliptop Vial (NDC 00409-2122-01) Next Delivery: March 2020; Estimated Recovery: June 2020 Shortage per manufacturer: Manufacturing Delay Other
2.5 mg/2 mL (1.25 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2122-02) Next Delivery: March 2020; Estimated Recovery: June 2020 Shortage per manufacturer: Manufacturing Delay Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English